Navigation Links
Cumberland Pharmaceuticals Reports First Quarter Financial Results
Date:5/2/2013

26413,841Net loss at subsidiary attributable to noncontrolling interests

13,3839,367Net income attributable to common shareholders

$

854,709$

423,208Earnings per share attributable to common shareholders- basic

$

0.05$

0.02- diluted

$

0.05$

0.02Weighted-average shares outstanding- basic

18,758,38320,007,998- diluted

18,925,16520,234,438Comprehensive income

$

841,326$

413,841 CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIESCondensed Consolidated Statements of Cash Flows(Unaudited)Three months ended March 31,20132012Cash flows from operating activities:Net income

$

841,326$

413,841Adjustments to reconcile net income to net cash provided by operating

activities:Depreciation and amortization expense

290,508217,263Deferred tax expense

65,413—Share-based compensation

128,625214,381Excess tax benefit derived from exercise of stock options

(478,698)(191,081)Noncash interest expense

6,0196,019Noncash investment gains (losses)

10,571(8,800)Net changes in assets and liabilities affecting operating activities:Accounts receivable

49,5702,619,523Inventory

226,324(230,784)Other current assets and other assets

(8,298)(324,954)Accounts payable and other current liabilities

492,983(282,862)Other long-term liabilities

46,308178,120Net cash provided by operating activities

1,670,6512,610,666Cash flows from investing activities:Additions to property and equipment

(60,911)(32,800)Purchases of marketable securities

(2,970,000)(15,992,822)Proceeds from sale of marketable securities

686,755—Additions to intangible assets

(961,013)(180,787)Net cash used in investment activities

(3,305,169)(16,206,409)Cash flows from financing activities:Net borrowings on lin
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results
2. Cumberland Pharmaceuticals To Present At The 2012 Wells Fargo Securities Healthcare Conference In Boston
3. Cumberland Pharmaceuticals To Announce Second Quarter 2012 Financial Results On August 2, 2012
4. Cumberland Pharmaceuticals Reports Second Quarter 2012 Financial Results
5. Cumberland Pharmaceuticals to Present at the UBS Global Life Sciences Conference in New York
6. Cumberland Pharmaceuticals Reports Third Quarter 2012 Financial Results
7. Cumberland Emerging Technologies Expands Life Sciences Center
8. Cumberland Pharmaceuticals And PT. SOHO Industri Pharmasi enter Into Exclusive Licensing Agreement For Caldolor In Indonesia
9. Cumberland Pharmaceuticals To Announce 2012 Year End Financial Results On February 28, 2013
10. Cumberland Pharmaceuticals Reports 2012 Annual Financial Results
11. Cumberland Pharmaceuticals To Announce First Quarter 2013 Financial Results On May 2, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Manufacturers, suppliers and distributors of innovative medical-related ... their most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the ... the most litigious industry sectors of cases involving ...
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: PharmaPoint: ... Market Analysis to 2022 ... - India Drug Forecast and Market Analysis ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
... reimbursement rates for home medical equipment and services (HME) ... as a result of Medicare,s bidding program going into ... largest metropolitan areas in the U.S. ... City, Miami, Orlando, Pittsburgh, and Riverside, California. The bidding ...
... Pa., Dec. 16, 2010 West Pharmaceutical Services, Inc. (NYSE: ... approved payment of the first-quarter 2011 cash dividend of $0.17 per ... shareholders of record on January 19, 2011. ... components and systems for injectable drug delivery, including stoppers and seals ...
Cached Medicine Technology:Problems Emerge in Competitive Bidding Pricing Scheme for Home Medical Equipment; Economists Predict the Program Will Fail 2Problems Emerge in Competitive Bidding Pricing Scheme for Home Medical Equipment; Economists Predict the Program Will Fail 3
(Date:4/17/2014)... Canadians surveyed said they would participate in public health ... genetic conditions, only 80 per cent said they would ... their newborns, genomes.,Most newborns in North America have a ... of life in which a tiny amount of blood ... five to 54 conditions, depending on the state or ...
(Date:4/17/2014)... An anti-malarial treatment that lost its status as the ... a new lease of life, with new research indicating ... findings could revive the use of the cheap anti-malarial ... which claims the lives of more than half a ... parasite that causes malaria has developed resistance to chloroquine, ...
(Date:4/16/2014)... The Translational Genomics Research Institute (TGen) recently honored two ... their support of TGen,s research into brain, colon and ... Scottsdale. , Catherine Ivy, Founder and President of The ... McCain Leadership Award, named for U.S. Sen. John McCain ...
(Date:4/16/2014)... DOWNERS GROVE, Ill. April 16, 2014 According ... surveillance colonoscopy in average-risk patients with one to two ... 90 percent of cases. This may be an appropriate ... endoscopic database study to quantify adherence to guidelines for ...
(Date:4/15/2014)... fish caused nearly half of all injuries aboard commercial ... freezer-longliner vessels operating off the coast of Alaska, new ... those injuries and others aboard the two types of ... the research methods used in the study could help ...
Breaking Medicine News(10 mins):Health News:Researcher looks at public perceptions around newborn testing 2Health News:Researcher looks at public perceptions around newborn testing 3Health News:Scientists find new way to fight malaria drug resistance 2Health News:TGen honors Catherine Ivy and Craig Jackson with Leadership; Collaborative Spirit awards 2Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 2Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 3Health News:Changes in processing, handling could reduce commercial fishing injuries 2
... , PLYMOUTH MEETING, Pa., Nov. 16 In this ... are scrutinizing costs and being forced to make tough decisions affecting ... technologies clamoring for attention, knowing which ones to focus on can ... asked by health plans around the country, ECRI Institute(R) ( ...
... 16 With health care reform taking the national ... that some form of change is necessary. Many health care ... government-mandated change because innovation has already begun to occur organically ... defining that innovation and garnering attention in the industry. , ...
... Other Requests: Harmonize Regulations and Avoid Duplicate Fees ... products pose a significant food safety hazard, facilities producing these ... regulations proposed so far this year by Congress. These facilities ... which are know as the Pasteurized Milk Ordinance (PMO), that ...
... But risk is highest for women with aura, researchers find ... migraines have more than double the risk of ischemic stroke, ... study has found. , Ischemic stroke, the most common type ... cut off by plaque accumulation or a blood clot. , ...
... As many software companies work to create programs that ... are reported, a new study by researchers at Wake Forest ... not improve, but rather decreases the completeness and accuracy of ... Radiology , compared the accuracy and completeness of reporting test ...
... 2009Although women have made strides in the business world, ... leadership positions in the Fortune 500. Not surprisingly therefore ... and most industries are considered to be male-typed at ... positions within a handful of industries, these industries are ...
Cached Medicine News:Health News:ECRI Institute Issues Health Plan Watch List: 2010 Top 7 Technologies; Exclusive Insights in White Paper, Available for Free Download 2Health News:ECRI Institute Issues Health Plan Watch List: 2010 Top 7 Technologies; Exclusive Insights in White Paper, Available for Free Download 3Health News:Health Care Robots: Next Generation Decision-Making Software, Eliminates Manual Systems Labor 2Health News:Health Care Robots: Next Generation Decision-Making Software, Eliminates Manual Systems Labor 3Health News:Dairy Groups Urge Senators to Include Raw Milk Facilities in Food Safety Regulations 2Health News:Dairy Groups Urge Senators to Include Raw Milk Facilities in Food Safety Regulations 3Health News:Migraine Increases Likelihood of Stroke 2Health News:Structured reporting software creates less complete and accurate radiology reports than free text 2Health News:Structured reporting software creates less complete and accurate radiology reports than free text 3
The PHOS method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of phosphorus in serum....
For the quantitative in vitro determination of total and direct bilirubin in serum or plasma....
For the quantitative in vitro determination of Anti-Streptolysin-O (ASO) in serum...
For the quantitative in vitro determination of IgA in serum and plasma. This product is suitable for use on Hitachi 704, 705, 717, 902, 911 and 912....
Medicine Products: